Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but They are really uncommon With this malignancy in comparison with other lymphoid neoplasms. CHD2 aberrations and suit adequate to tolerate FCR therapy, may still be good candidates with the latter, Whi